Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Katy Beckermann
Advertisement
Dr. Katy Beckermann is the medical director of Genitourinary Clinical Research, Medical Oncology, and a clinician scientist at the Tennessee Oncology Proton Center, in Franklin.
Articles by Dr. Katy Beckermann
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship
2
What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?
3
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
4
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
5
